Biotechnology

Investing in biotechnology

Galenicum has invested in two different projects:

• Bionure

  • Developing an NCE for multiple sclerosis
  • Potential applications also in the treatment of neuro-degenerative diseases such as Alzheimer's or Parkinson's
  • Based in the Parc Científic science park in Barcelona, and new offices will soon be opened in San Francisco
  www.bionure.com

• Azurebio

  Based in Madrid, led by Arcadio García, the company has three main projects:

  • New technologies in hypodermic needles
  • Synthetic bone for odontology applications
  • Development of reactives for analytical labs
  www.azurebio.com